http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0272129-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8dbdfc93841b3d731fbab7ea48b412a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-147
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C31-10
filingDate 1989-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40a28cf13ae5b9caddb6a5c2a6a2348b
publicationDate 1990-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0272129-A
titleOfInvention Preparation of enantiomerically pure 1,2-propanediol
abstract PURPOSE: To obtain an enantiomerically pure 1,2-propanediol useful in the preparation of a Ca blocker of verapamil and gallopamil by reacting L(-)-lactide or D(+)-lactide with a reducing agent and isolating the product. n CONSTITUTION: L(-)-Lactide or D(+)-lactide is reacted with a reducing agent (e.g. diisobutylaluminum hydride, triethoxy-silane) in an inert solvent (e.g. toluene, heptane) at 40-70°C and alkali-hydrolyzed, and then, the inert solvent is removed from the aqueous solution to separate precipitated Al(OH) 3 . Subsequently, the aqueous phase is condensed by evaporation and the residue is suspended in a suitable solvent to separate a solid reaction product by filtration and the solvent is removed, and then, the filtrate is distilled to obtain an enantiomerically pure 1,2-propanediol. n COPYRIGHT: (C)1990,JPO
priorityDate 1988-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544299
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415812542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456726312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6603929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13830

Total number of triples: 38.